Low Glycemic Index

We use organic or conventional ingredients based on the client's specifications and physiology. We source both plant and animal-based ingredients to formulate low-carbohydrate food and nutraceutical products. For instance, resistant starch (RS) has received much attention due to its positive influence on the functioning of the digestive tract, microbial flora, blood cholesterol level, and glycemic index. Besides, RS has desirable physicochemical properties such as viscosity, gel formation, swelling capacity and water-binding capacity, which make it useful in a variety of foods. We incorporate resistant starch from natural foods or commercial obtained (RS3 & RS4) to formulate our cereals, biscuits, baked goods, dairy products, nutrition bars and bread. Evidence also showed the RS4 incorporated bread has a low glycemic index than the reference part. Our procurement team from FRL FRL hunt for the latest innovations to identify best practices globally. For instance, Hi-maize®, NOVELOSE 330®, ActiStar®, and CrystalLean® have been identified by our team to incorporate into our formulation. We also incorporate cellulose, hemicelluloses, pectin, arabinoxylans, beta-glucan, glucomannans, plant gums and mucilages and hydrocolloids, all of which are principally found in the plant cell wall

We develop baked goods and confectionary products Bakery; Cookies & Candy; Dairy; Condiments, Oils & Salad Dressings; Cereal & Breakfast based food products, bars; Diet & Nutrition; Drinks; Frozen Food; Sauces, Spices and Seasonings; Snacks and meal kits /diet formulation with low carbohydrates using the latest technology and processing method at the same time maintaining shelf life and an appealing appearance, texture and taste.

FRL's scientists and formulation experts develop low glycemic products and meals with varying dosages that have the capacity to modulate the sensory quality and stabilizing properties as well. Using natural ingredients or different treatment processing methods and technology. For instance, triticale, rye and wheat starch composition favourable for RS3 generation after groats treatment. Phosphorylated cross-linked RS4 is produced commercially from wheat, potato, and tapioca starches in compliance with the Code of Federal Regulations (21 CFR 172.892), and this is safe under good manufacturing practices (21 CFR 172.892). Our team formulates a product that meets the desired shelf life and water activity with a permutation combination of methods.

We can formulate the products in the form of ready-to-drink, ready-to-serve, ready-to-eat, ready-to-cook, ready-to-drink, ready-to-mix protein powders, meal replacement drinks, meal kits, low carbohydrate ingredients, sports bars and formulations along with soft or hard gels, capsules, tablets, syrups, gummies, or sachets containing a concentrated source of minerals, vitamins, or botanical extracts.

FRL's scientists and formulation experts develop a highly functional strength product that provides the intended results. We adhere to the international guidelines and formulate our product to make the product high fibre, low or no sodium claim, low or no sugar claim, and low or no-fat (saturated fat), low/reduced carbohydrate claims at the same time meet the dairy-free claim as well. Our formulation experts ensure that the end product would meet the required pH, dispersibility, efficacious dosage, shelf life, glycemic index, desired satiety, mouthfeel, flavour, odor and taste. Through years of expertise and knowledge, we bring in the right solutions that fit your requirements.

Any ingredient incorporated into the formulation needs to achieve its intended function in the human body at the same time, must adhere to safety guidelines. At FRL, we substantiate this from many different types of investigation, including secondary research for existing ingredients or, if it's novel, publishing the work in reputable, peer-reviewed journals. Data for this will be derived from chemical comparisons and analysis, activities (e.g., ORAC or oxygen radical absorbance activities), testing in animal models, genomic/gene expression studies, in vitro bioassays and, most compelling of all, human clinical testing. Through years of expertise and knowledge, we bring in the right solutions that fit your requirements.

We follow quality measures to ensure the products are safe from both the supplier and the buyer's perspectives. We carry out Marker Chemistry (e.g., HPLC, GC etc.), Microbiology tests (e.g., Pseudomonas, Salmonella, Escherichia Coli), heavy metal analysis (e.g., lead, arsenic, cadmium kept below the regulatory limits), Contamination (e.g., metal flakes from machinery), physical characteristics (e.g., powders for tablets must have low moisture content) and stability (e.g., the time for a product from initial production). We use compendium methods (USP and European Pharmacopeia) for an extensive validation process.

We follow a specific set of regulations that a product must adhere to. This includes manufacturing flow chart, solvents, quantitative ingredient lists, physical characteristics, GMO status, certifications, radiations, pesticide/chemical/ residue, contaminants, microbiology, allergens, animal derivation, and safety (Standard Material Safety Data Sheet – toxicity or clinical testing). We assist ensure to clear the ingredient supplier completes clearance through the target country’s regulatory agency prior to its inclusion in formulas. Through our years of experience, our team can speed up the acceptance and inclusion of new material. Our product development team complies with the Food, Drug and Cosmetics Act (FDA 2009), DSHEA and the Fair Packaging and Labeling Act (Federal Trade Commission 2011), safety and quality food and food supplements guidelines delineated by WHO and the United Nations Food and Agricultural Organization (FAO). Our team ensures to use only acceptable ingredients that are found in the International Nomenclature. We also adhere to the local country’s guidelines as per the client’s request, such as for the Japanese Ministry of Health, Labor and Welfare (MHLW), The Chinese Health Care Association (CHCA), China’s State Food and Drug Administration (SFDA) and FSSAI.